By Corinne Murdock
The Association of American Physicians and Surgeons (AAPS) challenged the American Medical Association’s (AMA) recent take that ivermectin should no longer be prescribed for COVID-19.
In a letter to AMA President Gerald Harmon published Saturday, AAPS Executive Director and Tucson native Jane Orient argued that the AMA was contradicting the professional opinion of many respected physicians – those that are writing the average of 88,000 prescriptions a week for ivermectin. Orient cited 63 controlled studies that favor the use of ivermectin in treating COVID.
Orient also cited the Tokyo Medical Association (TMA), who issued a call to action in February for all their physicians to prescribe ivermectin to treat COVID-19. She asked AMA if they could answer the following questions about their rationale for opposing ivermectin:
- What are the criteria for advocating that pharmacists override the judgment of fully qualified physicians who are responsible for individual patients?
- What are the criteria for forbidding off-label use of long-approved drugs, which constitute at least 20 percent of all prescriptions?
- On what basis does AMA demand use only within a clinical trial for ivermectin, but call for virtually universal vaccination outside of controlled trials, despite FDA warnings of potential cardiac damage in healthy young patients, and no information about long-term effects?
The AMA issued their recommendation in a joint statement with the American Pharmacists Association (APhA) and the American Society of Health-System Pharmacists (ASHP) last week. The statement noted that they were alarmed by the 24-fold increase in ivermectin prescriptions over the course of the pandemic.
Recently, famed podcaster and comedian Joe Rogan was prescribed ivermectin as one of several treatments for his COVID-19. Rogan also reported using monoclonal antibodies, Z-Pack, and Prednisone. Within 5 days, Rogan went from fully symptomatic to testing negative.